These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 11167946)

  • 1. A shadow of Epstein-Barr virus in the pathogenesis of atopic diseases.
    Okudaira H; Shuto H; Shuto C; Chiba T; Akiyama H; Ohta I; Matsuzaki G
    Clin Exp Allergy; 2001 Jan; 31(1):18-24. PubMed ID: 11167946
    [No Abstract]   [Full Text] [Related]  

  • 2. Tight regulation of the Epstein-Barr virus setpoint: interindividual differences in Epstein-Barr virus DNA load are conserved after HIV infection.
    Piriou E; van Dort K; Otto S; van Oers MH; van Baarle D
    Clin Infect Dis; 2008 Jan; 46(2):313-6. PubMed ID: 18171268
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epstein-Barr virus in the development of multiple sclerosis.
    Ascherio A
    Expert Rev Neurother; 2008 Mar; 8(3):331-3. PubMed ID: 18345964
    [No Abstract]   [Full Text] [Related]  

  • 4. [Purification and application of viral capsid antigen of Epstein-Barr virus].
    Zhou W; Gu S
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 1997 Sep; 11(3):252-5. PubMed ID: 15617341
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epstein-Barr virus: Trigger for autoimmunity?
    Kaminski HJ; Minarovits J
    Ann Neurol; 2010 Jun; 67(6):697-8. PubMed ID: 20517931
    [No Abstract]   [Full Text] [Related]  

  • 6. Epstein-Barr virus and multiple sclerosis.
    Lovett-Racke AE; Racke MK
    Arch Neurol; 2006 Jun; 63(6):810-1. PubMed ID: 16769860
    [No Abstract]   [Full Text] [Related]  

  • 7. Epstein-Barr virus and rheumatoid arthritis.
    Sawada S; Takei M
    J Rheumatol; 2001 Oct; 28(10):2363-4. PubMed ID: 11669183
    [No Abstract]   [Full Text] [Related]  

  • 8. Epstein-barr virus vaccination of transplant candidates: light at the end of the tunnel?
    Allen UD
    Transplantation; 2009 Oct; 88(8):976-7. PubMed ID: 19855241
    [No Abstract]   [Full Text] [Related]  

  • 9. Diagnostic evaluation of a new panel of assays for Epstein-Barr virus serology.
    Radtke M; Gärtner B; Franke D
    Clin Lab; 2007; 53(3-4):149-50. PubMed ID: 17447650
    [No Abstract]   [Full Text] [Related]  

  • 10. Epstein-Barr virus and systemic lupus erythematosus.
    James JA; Harley JB; Scofield RH
    Curr Opin Rheumatol; 2006 Sep; 18(5):462-7. PubMed ID: 16896283
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The immunology of Epstein-Barr virus infection.
    Moss DJ; Burrows SR; Silins SL; Misko I; Khanna R
    Philos Trans R Soc Lond B Biol Sci; 2001 Apr; 356(1408):475-88. PubMed ID: 11313006
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epstein-Barr virus and multiple sclerosis: causation or association?
    Kakalacheva K; Comabella M
    Future Microbiol; 2010 Nov; 5(11):1617-9. PubMed ID: 21133682
    [No Abstract]   [Full Text] [Related]  

  • 13. Acute upper gastrointestinal bleeding associated with Epstein-Barr virus reactivation in an immunocompetent patient.
    Lavín AC; Román JG; Zárate SA; Porras MC; Caviedes JR
    Am J Gastroenterol; 2009 Jan; 104(1):253-4. PubMed ID: 19098888
    [No Abstract]   [Full Text] [Related]  

  • 14. Quantitative analysis of Epstein-Barr virus (EBV)-specific CD8+ T cells in patients with chronic active EBV infection.
    Sugaya N; Kimura H; Hara S; Hoshino Y; Kojima S; Morishima T; Tsurumi T; Kuzushima K
    J Infect Dis; 2004 Sep; 190(5):985-8. PubMed ID: 15295706
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation and dysregulation of Epstein-Barr virus latency: implications for the development of autoimmune diseases.
    Niller HH; Wolf H; Minarovits J
    Autoimmunity; 2008 May; 41(4):298-328. PubMed ID: 18432410
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regression assay.
    Frisan T; Levitsky V; Masucci M
    Methods Mol Biol; 2001; 174():199-201. PubMed ID: 11357644
    [No Abstract]   [Full Text] [Related]  

  • 17. Epstein-Barr virus: a paradigm for persistent infection - for real and in virtual reality.
    Thorley-Lawson DA; Duca KA; Shapiro M
    Trends Immunol; 2008 Apr; 29(4):195-201. PubMed ID: 18328785
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Limiting dilution assay.
    Frisan T; Levitsky V; Masucci M
    Methods Mol Biol; 2001; 174():213-6. PubMed ID: 11357647
    [No Abstract]   [Full Text] [Related]  

  • 19. Antibodies for detecting EBV latent proteins.
    Rowe M; Mehl A
    Methods Mol Biol; 2001; 174():219-27. PubMed ID: 11357648
    [No Abstract]   [Full Text] [Related]  

  • 20. Immunotherapy with virus-specific cytotoxic T lymphocytes after organ transplantation.
    Lucas KG; Sun Q
    Pediatr Transplant; 2006 Mar; 10(2):142-4. PubMed ID: 16573596
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.